Testicular cancer laboratory findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
==Laboratory Tests== | ==Laboratory Tests== | ||
'''Tumor marker tests:'''<ref name="pmid24198649">{{cite journal |vauthors=Milose JC, Filson CP, Weizer AZ, Hafez KS, Montgomery JS |title=Role of biochemical markers in testicular cancer: diagnosis, staging, and surveillance |journal=Open Access J Urol |volume=4 |issue= |pages=1–8 |date=December 2011 |pmid=24198649 |pmc=3818947 |doi=10.2147/OAJU.S15063 |url=}}</ref> | '''Tumor marker tests:'''<ref name="pmid24198649">{{cite journal |vauthors=Milose JC, Filson CP, Weizer AZ, Hafez KS, Montgomery JS |title=Role of biochemical markers in testicular cancer: diagnosis, staging, and surveillance |journal=Open Access J Urol |volume=4 |issue= |pages=1–8 |date=December 2011 |pmid=24198649 |pmc=3818947 |doi=10.2147/OAJU.S15063 |url=}}</ref><ref name="pmid20530278">{{cite journal |vauthors=Gilligan TD, Seidenfeld J, Basch EM, Einhorn LH, Fancher T, Smith DC, Stephenson AJ, Vaughn DJ, Cosby R, Hayes DF |title=American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors |journal=J. Clin. Oncol. |volume=28 |issue=20 |pages=3388–404 |date=July 2010 |pmid=20530278 |doi=10.1200/JCO.2009.26.4481 |url=}}</ref> | ||
{| class="wikitable" | {| class="wikitable" | ||
|+ | |+ | ||
Revision as of 17:18, 1 March 2019
|
Testicular cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Testicular cancer laboratory findings On the Web |
|
American Roentgen Ray Society Images of Testicular cancer laboratory findings |
|
Risk calculators and risk factors for Testicular cancer laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Gertrude Djouka, M.D.[2], Shanshan Cen, M.D. [3]
Overview
An elevated concentration of blood tumor marker tests is diagnostic of testicular cancer.
Laboratory Tests
| Tumor type | Tumor markers | ||
|---|---|---|---|
| HCG | AFP | LDH | |
| Seminomas | ↑ | - | ↑ |
| Choriocarcinoma | ↑↑ | - | ↑ |
| Yolk sack | - | ↑ | ↑ |
| Embryonal | ↑ | ↑ | ↑ |
| Teratoma | - | ↑ | ↑ |
- Alpha-fetoprotein (AFP)
- Human chorionic gonadotropin (HCG)
- Lactate dehydrogenase (LDH)
References
- ↑ Milose JC, Filson CP, Weizer AZ, Hafez KS, Montgomery JS (December 2011). "Role of biochemical markers in testicular cancer: diagnosis, staging, and surveillance". Open Access J Urol. 4: 1–8. doi:10.2147/OAJU.S15063. PMC 3818947. PMID 24198649.
- ↑ Gilligan TD, Seidenfeld J, Basch EM, Einhorn LH, Fancher T, Smith DC, Stephenson AJ, Vaughn DJ, Cosby R, Hayes DF (July 2010). "American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors". J. Clin. Oncol. 28 (20): 3388–404. doi:10.1200/JCO.2009.26.4481. PMID 20530278.